Table 2. Mean baseline and change from baseline in clinical outcomes

From

200 U vs 300 U Botulinum Toxin A Injections for Patients with Neurogenic Detrusor Overactivity Secondary to Spinal Cord Injury

Lin JM, Chen Hui, Liu QL, Huang MP, Li QQ, Huang TH, Yang XY

American Journal of Medical Case Reports. 2019, 7(10), 250-252 doi:10.12691/ajmcr-7-10-7